| Sumario: | The global market for advanced wound care products is large and growing rapidly. International industry analysts estimate the global wound care market at US$20.3b, and $2.6b in Australia. Growth in the market is robust, estimated at more than 5% annually, attributed not only to demographic changes (that is to say, ageing, diabetes, obesity), but also to rising health care costs. This has led to a plethora of new products, approaches and treatments being trialled and marketed for the treatment of non-healing, chronic wounds. However, this smorgasbord of approaches for wound management brings with it its own issues and challenges as clinicians try to keep abreast of new treatment options and management choices. While some of these advanced wound therapies have been subject to rigorous clinical trials, many have little evidence to support their use in wound care situations. In this review we have focussed on some of the new approaches and therapies which are currently under development or in clinical use for the treatment of chronic wounds and burns.
|
|---|